SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ytterberg, H.
Right arrow Articles by Edvinsson, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ytterberg, H.
Right arrow Articles by Edvinsson, L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Characterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries

Hoa Ytterberg

Department of Experimental Vascular Research, Department of Internal Medicine, Lund University Hospital, Lund, Sweden, hoa{at}ytterberg.com

Lars Edvinsson

Department of Experimental Vascular Research, Department of Internal Medicine, Lund University Hospital, Lund, Sweden

Subcutaneous arteries have been used as a model for resistance arteries, which are potentially involved in enhanced blood pressure (BP) regulation in man. Angiotensin II (Ang II) is an important regulator of tone, acting via type 1 (AT1-) and type 2 (AT2-) receptor subtypes. The aim of this study was to characterise the Ang II receptors in isolated human subcutaneous arteries, using pharmacological and molecular methods.

Subcutaneous arteries were obtained from patients undergoing elective gut surgery and were carefully dissected from the abdominal wall. Cylindrical segments were mounted on two L-shaped metal prongs, one of which was connected to a force-displacement transducer for continuous recording of isometric tension. Concentration-response curves to Ang II were constructed in the presence and absence of various selective AT1-receptor antagonists, candesartan, EXP3174, irbesartan and losartan, and the AT2-receptor antagonist, PD 123319. Responses to Ang II were measured as increases in force (mN) and expressed as a percentage of the response to 60 mM of KCl. Ang II caused a concentration-dependent contraction (pEC50=9.45±0.48, Emax=120±13%). Candesartan and EXP3174 caused concentration-dependent depression of the Emax of Ang II without any major shift of pEC50. Losartan and irbesartan caused a significant, dose-dependent rightward shift of the Ang II contraction-response curve in human subcutaneous arteries. The results show that contractile responses of human subcutaneous arteries are mediated via the AT1-receptor. The AT1-receptor antagonists, candesartan and EXP3174, acted in an insurmountable manner, while losartan and irbesartan were surmountable AT1-receptor antagonists. The AT2-receptor antagonist, PD 123319, (10, 100 nM) had no effect on Ang II-induced contraction. This is supported by the positive identification of mRNA for the human AT 1-receptor by RT-PCR.

Key Words: Ang II • AT1- and AT2-receptors • candesartan • EXP3174 • irbesartan • losartan • RT-PCR • PD 123319 • subcutaneous arteries

References

  • Dzau VJ Multiple pathways of angiotensin production in the blood vessel wall, possibilities and hypotheses. J Hypertens 1989;12:933-6.
  • Kifor I., Dzau VJ Endothelial renin-angiotensin pathway: Evidence for intracellular synthesis and secretion of angiotensins. Cir Res 1987;3:422-30.
  • Mizuno K., Higashimori K., Inagami T. Direct evidence for the local generation of vascular Ang II and its prostaglandin-mediated release from isolated hind legs in the rat. J Hypertens 1988; (Suppl 6) (4):S435-442.[CrossRef][Web of Science]
  • Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA, Alexander RW Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulation muscle cells. J Biol Chem 1986;13:5901-6.
  • Furuta H., Guo D., Inagami T. Molecular cloning and sequencing of gene encoding human Ang II type I receptor Biochem Biophys Res Commun 1992;183:8-13.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsuzuki S., Ichiki T., Nakakubo H. et al. Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor. Biochem Biophys Res Commun 1994;3:1449-54.
  • Hirsch,AT, Talsness CE, Schankert H., Paul M., Dzau VJ Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991;69: 475-82.[Abstract/Free Full Text]
  • Brown L., Sernia C. Angiotensin receptors in cardiovascular diseases, Clin Exp Pharmacol Physiol 1994;21: 811-9.[Web of Science][Medline] [Order article via Infotrieve]
  • Hamel E.,Assumel-Lurdin C., Edvinsson L., Page P., Mackenzie ET Neuronal versus endothelial origin of vasoactive acetylcholine in pial vessels. Brain Res 1987;420:391-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Högestätt ED, Andersson KE, Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small vessels.Acta Physiol Scand 1983;117:449-61.
  • Tallarida RJ, Cowen A., Adler MV pA2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci 1979;25(8):637-54 (Review).[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bergsma D., Ellis C., Kumar C. Cloning and characterization of a human angiotensin II typer 1 receptor. Biochem Biophys Res Commun 1992;183:989-95.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Martin M., Su B., Elton T. Molecular cloning of the human Ang II type 2 receptor cDNA. Biochem Biophys Res Commun 1994;205:645-51.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Holmgren A., Pantev E., Erlinge D., Edvinsson L. Inhibition of Ang II-induced contraction by losartan in human coronary arteries. J Cardiovasc Pharmacol 1998;32:662-4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Garcha RS, Sever PS, Hughes AD Action of antagonists on angiotensin II-induced tone in human isolated subcutaneous arteries. Br J Pharmacol 1999;127:1876-82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ytterberg H., Edvinsson L. Evidence for a cyclic AMP-dependent pathway in angiotensin AT1-receptor activation of human omental arteries. JRAAS 2001;2(suppl 1):S42-S47.
  • ZwartAS, Davis EA,Widdop RE Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2-receptor. Br J Pharmacol 1998;125:1429-36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Morsing P., Abrahamson T. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Hypertension 1999;33:1406-13.[Abstract/Free Full Text]
  • Vanderheyden PML, Vauquelin G. Distinction between surmountable and insurmountable selective AT1-receptor antagonists by use of CHO-K1 cells expressing human Ang II AT1 receptors. Br J Pharmacol 1999; 126:1057-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hollenberg NK, Sever, PS The past, present and future of hypertension management: a potential role for AT1-receptor antagonists. JRAAS 2000;1:5-10.[Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 1 suppl, S37-S41 (2001)
DOI: 10.1177/14703203010020010601
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ytterberg, H.
Right arrow Articles by Edvinsson, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ytterberg, H.
Right arrow Articles by Edvinsson, L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement